TACS

CAS : 111298-82-9

Ref. 3D-LEA29882

Informations sur le produit

• Nom: TACS
• Synonymes: 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-amino-3-[[[5-(carboxymethyl)-4-methyl-2-thiazolyl]thio]methyl]-8-oxo-, (6R-trans)-, (6R,7R)-7-Amino-3-[[[5-(carboxymethyl)-4-methyl-2-thiazolyl]thio]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-amino-3-[[[5-(carboxymethyl)-4-methyl-2-thiazolyl]thio]methyl]-8-oxo-, (6R,7R)-

Description

TACS is a medicinal product that has been developed to target cancer cells and induce apoptosis, or programmed cell death. It contains a Chinese protein that has been shown to have anticancer properties in vitro and in vivo. TACS also contains nintedanib, which is a kinase inhibitor that targets the tumor microenvironment and disrupts the cell cycle of cancer cells. This product has been found to be effective against various types of human cancers, including leukemia. The inhibitors present in TACS work by blocking the growth and spread of cancer cells, making it a promising option for those seeking alternative treatments for cancer.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 401.5 g/mol
• Formule: C₁₄H₁₅N₃O₅S₃
• Degré de pureté: Min. 95%